Lufthansa Cargo has announced the successful renewal of its IATA CEIV Pharma certification, which will remain valid through 2029. This re-certification process involved a thorough evaluation of the airline's corporate approach to pharmaceutical handling, including its central quality management systems, dedicated pharma hubs, and selected operational stations. Audits for this renewal were completed in 2026.
This certification is crucial for air cargo carriers specializing in temperature-sensitive and time-critical pharmaceutical shipments. It signifies that Lufthansa Cargo meets the high industry standards set by IATA for the safe and secure transport of pharmaceutical products.
For freight forwarders and shippers, this renewal provides continued assurance regarding the integrity and quality of pharmaceutical logistics services offered by Lufthansa Cargo. It helps mitigate risks associated with temperature excursions and handling errors, which are critical concerns for high-value and sensitive medical cargo. Forwarders can confidently book pharma shipments, knowing the carrier adheres to globally recognized best practices, potentially simplifying compliance and reducing the need for extensive due diligence on their part.
The extended validity until 2029 indicates a stable and reliable partner for pharmaceutical supply chains in the coming years.
